Cyanine7.5 hydrazide

Cat. # Quantity Price Lead time
16070 1 mg $110.00 in stock
26070 5 mg $210.00 in stock
46070 25 mg $410.00 in stock
56070 50 mg $695.00 in stock
66070 100 mg $1190.00 in stock

A carbonyl-reactive hydrazide derivative of Cyanine7.5 near infrared (NIR) fluorophore. This dye has similar spectral properties with ICG (indocyanine green), but has a higher quantum yield of fluorescence. Hence, this fluorophore is ideal for in vivo imaging.

This is a carbonyl-reactive dye which is particularly useful for the labeling of antibodies after periodate oxidation. It also labels other carbonyl compounds (aldehydes and ketones), for example, many saccharides.

Cyanine7.5 absorbance and emission spectra

Cyanine7.5 absorbance and emission spectra

Customers also purchased with this product

Biotin alkyne

Biotin alkyne is a reactive affinity label which can be attached to biomolecules via Click Chemistry.

Cyanine5.5 NHS ester

Cyanine5.5 NHS is far-red / near-infrared amine-reactive dye.
Add this product to your cart and
get free express delivery

JOE alkyne, 6-isomer

JOE dye alkyne derivative for copper catalyzed Click chemistry reaction with azides. JOE dye is often used for nucleic acid labeling.

General properties

Appearance: green powder
Mass spec M+ increment: 644.4
Molecular weight: 735.82
Molecular formula: C45H52Cl2N4O
Solubility: moderate solubility in water, good in polar organic solvents (DMF, DMSO, alcohols)
Quality control: NMR 1H, HPLC-MS (95%)
Storage conditions: Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate.
MSDS: Download
Product specifications

Spectral properties

Excitation/absorption maximum, nm: 788
ε, L⋅mol−1⋅cm−1: 223000
Emission maximum, nm: 808

Product citations

  1. Liu, S.; Dozois, M.D.; Chang, C.N.; Ahmad, A.; Ng, D.L.T.; Hileeto, D.; Liang, H.; Reyad, M.-M.; Boyd, S.; Jones, L.W.; Gu, F.X. Prolonged Ocular Retention of Mucoadhesive Nanoparticle Eye Drop Formulation Enables Treatment of Eye Diseases Using Significantly Reduced Dosage. Molecular Pharmaceutics, 2016, 13(9), 2897–2905. doi: 10.1021/acs.molpharmaceut.6b00445
Your item has been added. View your cart or proceed to checkout
The count of items is incorrect.